Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Lazo-Langner

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Journal of Thrombosis and Haemostasis : JTH|July 16, 2010
Anticoagulant response after dalteparin overdoseK Hasan, A Lazo-Langner, R Acedillo, et al.
Journal of Thrombosis and Haemostasis : JTH|July 15, 2010
Ambulatory management of pulmonary embolism: a pragmatic evaluationM J Kovacs, J D Hawel, J F Rekman, et al.
Rheumatology (Oxford, England)|February 18, 2006
Moderate and severe neutropenia in patients with systemic lupus erythematosusD Martínez-Baños, J C Crispín, A Lazo-Langner, et al.
Journal of Thrombosis and Haemostasis : JTH|July 16, 2013
Clinical performance of bleeding risk scores for predicting major and clinically relevant non-major bleeding events in patients receiving warfarinS Burgess, N Crown, M L Louzada, et al.
BMJ Open|September 14, 2021
MUFFIN-PTS trial, Micronized Purified Flavonoid Fraction for the Treatment of Post-Thrombotic Syndrome: protocol of a randomised controlled trialJean Philippe Galanaud, Jameel Abdulrehman, A Lazo-Langner, et al.
Current Oncology (Toronto, Ont.)|April 26, 2014
Patient preferences for stopping tyrosine kinase inhibitors in chronic myeloid leukemiaD Sanford, R Kyle, A Lazo-Langner, et al.
Current Oncology (Toronto, Ont.)|May 3, 2018
Adherence to, and outcomes of, a galactomannan screening protocol in high-risk hematology patientsS Harricharan, K Biederman, A M Bombassaro, et al.
Thrombosis Research|April 19, 2017
A prospective study of Rivaroxaban for central venous catheter associated upper extremity deep vein thrombosis in cancer patients (Catheter 2)G A Davies, A Lazo-Langner, E Gandara, et al.
Current Oncology (Toronto, Ont.)|February 17, 2015
Clinical challenges in patients with cancer-associated thrombosis: Canadian expert consensus recommendationsM Carrier, A Lazo-Langner, S Shivakumar, et al.
Journal of Thrombosis and Haemostasis : JTH|August 1, 2007
Long-term dalteparin in pregnancy not associated with a decrease in bone mineral density: substudy of a randomized controlled trialM A Rodger, S R Kahn, A Cranney, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Journal of Thrombosis and Haemostasis : JTH|July 16, 2010
Anticoagulant response after dalteparin overdoseK Hasan, A Lazo-Langner, R Acedillo, et al.
Journal of Thrombosis and Haemostasis : JTH|July 15, 2010
Ambulatory management of pulmonary embolism: a pragmatic evaluationM J Kovacs, J D Hawel, J F Rekman, et al.
Rheumatology (Oxford, England)|February 18, 2006
Moderate and severe neutropenia in patients with systemic lupus erythematosusD Martínez-Baños, J C Crispín, A Lazo-Langner, et al.
Journal of Thrombosis and Haemostasis : JTH|July 16, 2013
Clinical performance of bleeding risk scores for predicting major and clinically relevant non-major bleeding events in patients receiving warfarinS Burgess, N Crown, M L Louzada, et al.
BMJ Open|September 14, 2021
MUFFIN-PTS trial, Micronized Purified Flavonoid Fraction for the Treatment of Post-Thrombotic Syndrome: protocol of a randomised controlled trialJean Philippe Galanaud, Jameel Abdulrehman, A Lazo-Langner, et al.
Current Oncology (Toronto, Ont.)|April 26, 2014
Patient preferences for stopping tyrosine kinase inhibitors in chronic myeloid leukemiaD Sanford, R Kyle, A Lazo-Langner, et al.
Current Oncology (Toronto, Ont.)|May 3, 2018
Adherence to, and outcomes of, a galactomannan screening protocol in high-risk hematology patientsS Harricharan, K Biederman, A M Bombassaro, et al.
Thrombosis Research|April 19, 2017
A prospective study of Rivaroxaban for central venous catheter associated upper extremity deep vein thrombosis in cancer patients (Catheter 2)G A Davies, A Lazo-Langner, E Gandara, et al.
Current Oncology (Toronto, Ont.)|February 17, 2015
Clinical challenges in patients with cancer-associated thrombosis: Canadian expert consensus recommendationsM Carrier, A Lazo-Langner, S Shivakumar, et al.
Journal of Thrombosis and Haemostasis : JTH|August 1, 2007
Long-term dalteparin in pregnancy not associated with a decrease in bone mineral density: substudy of a randomized controlled trialM A Rodger, S R Kahn, A Cranney, et al.
Pageof 3